Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study

By Happich M.   Breitscheidel L.   Meisinger C.   Ulbig M.   Falkenstein P.   Benter U.   Watkins J.  

Current Medical Research and Opinion, Vol. 23, Iss. 6, 2007-06 ,pp. : 1367-1374

Informa Healthcare

Access to resources Recommend Favorite

Anti‐oxidative effect of the β‐blocker carvedilol on diabetic nephropathy in non‐obese type 2 diabetic rats

By  

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 9, 2015-09 ,pp. : 972-978

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effect of irbesartan in reducing cardiovascular risk in hypertensive type 2 diabetic patients: an observational study in 16 600 patients in primary care

By Bramlage P.   Pittrow D.   Kirch W.  

Current Medical Research and Opinion, Vol. 20, Iss. 10, 2004-10 ,pp. : 1625-1631

Informa Healthcare

Access to resources Recommend Favorite

Older type 2 diabetic patients are more likely to achieve glycaemic and cardiovascular risk factors targets than younger patients: analysis of a primary care database

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 12, 2015-12 ,pp. : 1486-1495

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lifestyle management: preventing Type 2 diabetes and cardiovascular complications

By Stiegler Rebecca S   Zimmet Paul Z   Cameron Adrian J   Shaw Jonathan E  

Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. : 489-496

Future Medicine

Access to resources Recommend Favorite